Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ji H, Yang"'
Autor:
Rafaela N. Barcelos, Cléber P. Camacho, Maria da Conceição de O. C. Mamone, Elza S. Ikejiri, Felipe A. B. Vanderlei, Ji H. Yang, Rosália P. Padovani, Leandro A. L. Martins, Rosa Paula M. Biscolla, Danielle Macellaro, Susan C. Lindsey, Rui M. B. Maciel, João Roberto M. Martins
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 67, Iss 6 (2023)
ABSTRACT Objective: The risk of malignancy and diagnostic accuracy of fine-needle aspiration biopsy (FNAB) of thyroid nodules (TN) with diameters ≥ 3-4 cm remains controversial. However, some groups have indicated surgical treatment in these patien
Externí odkaz:
https://doaj.org/article/92041d5b37f84dfa9eadce2496eca8ee
Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the BrasMEN study
Autor:
Rui M B Maciel, Cleber P Camacho, Lígia V M Assumpção, Natassia E Bufalo, André L Carvalho, Gisah A de Carvalho, Luciana A Castroneves, Francisco M de Castro Jr, Lucieli Ceolin, Janete M Cerutti, Rossana Corbo, Tânia M B L Ferraz, Carla V Ferreira, M Inez C França, Henrique C R Galvão, Fausto Germano-Neto, Hans Graf, Alexander A L Jorge, Ilda S Kunii, Márcio W Lauria, Vera L G Leal, Susan C Lindsey, Delmar M Lourenço Jr, Léa M Z Maciel, Patrícia K R Magalhães, João R M Martins, M Cecília Martins-Costa, Gláucia M F S Mazeto, Anelise I Impellizzeri, Célia R Nogueira, Edenir I Palmero, Cencita H C N Pessoa, Bibiana Prada, Débora R Siqueira, Maria Sharmila A Sousa, Rodrigo A Toledo, Flávia O F Valente, Fernanda Vaisman, Laura S Ward, Shana S Weber, Rita V Weiss, Ji H Yang, Magnus R Dias-da-Silva, Ana O Hoff, Sergio P A Toledo, Ana L Maia
Publikováno v:
Endocrine Connections, Vol 8, Iss 3, Pp 289-298 (2019)
Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant genetic disease caused by RET gene germline mutations that is characterized by medullary thyroid carcinoma (MTC) associated with other endocrine tumors. Several reports have demonstr
Externí odkaz:
https://doaj.org/article/37d0d78e06b24b48bb6c7725c95f14cc
Autor:
Ji H. Yang, Rui M. B. Maciel, Claudia C. D. Nakabashi, Carolina C. P. S. Janovsky, Rosalia P. Padovani, Danielle Macellaro, Cléber P. Camacho, Akemi Osawa, Jairo Wagner, Rosa Paula M. Biscolla
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 61, Iss 5, Pp 416-425 (2017)
ABSTRACT Objective To evaluate the clinical utility of 18F-FDG PET/CT in patients with high-risk DTC. Subjects and methods Single-center retrospective study with 74 patients with high-risk differentiated thyroid cancer (DTC), classified in 4 groups.
Externí odkaz:
https://doaj.org/article/930fb6d03ae84d30b0df014b0ffa3b4f
Autor:
Cleber P. Camacho, Lilian Yuri Itaya Yamaga, Ji H. Yang, Jairo Wagner, Flávia O. F. Valente, Susan C. Lindsey, Rui M. B. Maciel, Danielle M. Andreoni, Rosa Paula M. Biscolla
Publikováno v:
Endocrine Practice. 23:942-948
Objective: Calcitonin and carcinoembryonic antigen (CEA) doubling times are established prognostic markers in medullary thyroid cancer (MTC). On the other hand, 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19ffbed8f1c8dd483577dc53da1ca3a6
https://doi.org/10.4158/ep171806.or
https://doi.org/10.4158/ep171806.or
Autor:
Jairo Wagner, Cleber P. Camacho, Ji H. Yang, Lilian Yuri Itaya Yamaga, Marcelo Livorsi da Cunha, Marcelo Buarque de Gusmão Funari, Marcio Ricardo Taveira Garcia, Guilherme de Carvalho Campos Neto
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 44:1695-1701
Purpose The aim of this study was to prospectively compare the detection rate of 68Ga-DOTATATE PET-CT with 111In-octreotide SPECT-CT and conventional imaging (CI) in medullary thyroid carcinoma (MTC) patients with increased calcitonin (Ctn) levels bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbe748451cbaa71721af3f849b93816b
https://doi.org/10.1007/s00259-017-3701-9
https://doi.org/10.1007/s00259-017-3701-9
Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the BrasMEN study
Autor:
Léa Maria Zanini Maciel, Carla Vaz Ferreira, Sergio P. A. Toledo, Flávia O. F. Valente, Luciana A. Castroneves, Rui M. B. Maciel, Gisah Amaral de Carvalho, Rita V Weiss, Janete M. Cerutti, Henrique de Campos Reis Galvão, Tânia M B L Ferraz, Célia Regina Nogueira, Patrícia Künzle Ribeiro Magalhães, Francisco M de Castro, Shana de Souto Weber, Vera L.G. Leal, Cencita H. C. N. Pessoa, M Inez C França, Natassia Elena Bufalo, Gláucia Maria Ferreira da Silva Mazeto, Maria A. Sousa, Ji H. Yang, Bibiana Prada, Débora Rodrigues Siqueira, M Cecília Martins-Costa, Magnus R. Dias-da-Silva, Rossana Corbo, João Roberto Maciel Martins, Ana Luiza Maia, Ana O. Hoff, Delmar M. Lourenço, Laura Sterian Ward, Edenir Inêz Palmero, Hans Graf, Marcio W Lauria, Rodrigo A. Toledo, Alexander A. L. Jorge, Ligia V. M. Assumpção, Anelise I Impellizzeri, Ilda S. Kunii, Fernanda Vaisman, Lucieli Ceolin, Fausto Germano-Neto, André Lopes Carvalho, Susan C. Lindsey, Cleber P. Camacho
Publikováno v:
Endocrine Connections
Endocrine Connections, Vol 8, Iss 3, Pp 289-298 (2019)
Endocrine Connections, Vol 8, Iss 3, Pp 289-298 (2019)
Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant genetic disease caused by RET gene germline mutations that is characterized by medullary thyroid carcinoma (MTC) associated with other endocrine tumors. Several reports have demonstr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce317c959d2774e9d3360c02699a4a69
https://pubmed.ncbi.nlm.nih.gov/30763276
https://pubmed.ncbi.nlm.nih.gov/30763276
Autor:
Rosalia P. Padovani, Elsa S Ikejiri, Felipe Augusto Brasileiro Vanderlei, Rui M. B. Maciel, Ji H. Yang, Maria Conceição Mamone, Kassia B Reuters, Cláudia C. D. Nakabashi, Danielle M. Andreoni, Rosa Paula M. Biscolla, Carolina Castro Porto Silva Janovsky, Cleber P. Camacho
Background The Bethesda System has been used to classify thyroid cytology in 6 categories besides presenting malignancy rates and respective approaches. Reference centers have validated its use by comparing its proposed malignancy rates with those in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b29902ef1cb2a2d8ffd69c1e1aba43ba
https://europepmc.org/articles/PMC6047492/
https://europepmc.org/articles/PMC6047492/
Autor:
Rosa Paula M. Biscolla, Maria Conceição Mamone, Susan C. Lindsey, Rui M. B. Maciel, R. M. Tuttle, Magnus R. Dias-da-Silva, Fabio Brodskyn, Cleber P. Camacho, Alberto L. Machado, Fausto Germano-Neto, Flávia O. F. Valente, Ji H. Yang
Publikováno v:
Clinical Endocrinology. 83:938-942
Objective Staging systems applied to medullary thyroid cancer (MTC) rely on initial clinical and pathological features and do not consider the response to treatment. To determine whether MTC staging can be improved by incorporating the first postoper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d954ee1f3d66e73ad982afe523f051f0
https://doi.org/10.1111/cen.12657
https://doi.org/10.1111/cen.12657
Autor:
Ji H, Yang, Cléber P, Camacho, Susan C, Lindsey, Flavia O F, Valente, Danielle M, Andreoni, Lilian Y, Yamaga, Jairo, Wagner, Rosa Paula M, Biscolla, Rui M B, Maciel
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 23(8)
Calcitonin and carcinoembryonic antigen (CEA) doubling times are established prognostic markers in medullary thyroid cancer (MTC). On the other hand,Medical records of 17 patients with MTC who underwentEight patients presented with progressive diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8959c431c1ef05bef8ae090724fbef12
https://pubmed.ncbi.nlm.nih.gov/28614009
https://pubmed.ncbi.nlm.nih.gov/28614009
Autor:
Flávia O. F. Valente, Janete M. Cerutti, Rosa Paula M. Biscolla, Magnus R. Dias-da-Silva, Cleber P. Camacho, Rui M. B. Maciel, Maria Clara C. Melo, Thiago R.N. Lima, José Gilberto H. Vieira, Susan C. Lindsey, Ji H. Yang, Fausto Germano-Neto
Publikováno v:
Thyroid. 23:308-316
Serum calcitonin (sCT) is the main tumor marker for medullary thyroid cancer (MTC), but it has certain limitations. Various sCT assays may have important intra-assay or interassay variation and may yield different and sometimes conflicting results. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2354036d59abc44302aed115d59d23e4
https://doi.org/10.1089/thy.2012.0361
https://doi.org/10.1089/thy.2012.0361